Portola Pharmaceuticals
Investigational Drug Stops Serious Bleeds in Patients Taking Factor Xa Inhibitors
About 84,000 patients taking factor Xa inhibitors are hospitalized for major bleeding each year.
MARCH 15, 2018
FDA Approves Bevyxxa for VTE
Patients hospitalized for an acute medical illness are at risk for thromboembolic complications due to moderate or ...
JUNE 27, 2017
FDA Wants More Info Before Approving AndexXa
The FDA asked Portola Pharmaceuticals Inc. for more information regarding its BLA for andexanet alfa (AndexXa).
AUGUST 22, 2016
Load more